Aridis Pharmaceuticals Inc (ARDS)
0.0574
0.00 (0.00%)
USD |
OTCM |
May 17, 15:32
Aridis Pharmaceuticals Total Assets (Quarterly): 6.534M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 6.534M |
June 30, 2023 | 6.482M |
March 31, 2023 | 9.434M |
December 31, 2022 | 14.70M |
September 30, 2022 | 12.12M |
June 30, 2022 | 16.69M |
March 31, 2022 | 23.82M |
December 31, 2021 | 26.80M |
September 30, 2021 | 26.08M |
June 30, 2021 | 11.39M |
March 31, 2021 | 17.57M |
December 31, 2020 | 15.12M |
Date | Value |
---|---|
September 30, 2020 | 12.11M |
June 30, 2020 | 18.12M |
March 31, 2020 | 22.01M |
December 31, 2019 | 27.97M |
September 30, 2019 | 34.37M |
June 30, 2019 | 15.87M |
March 31, 2019 | 23.25M |
December 31, 2018 | 31.61M |
September 30, 2018 | 38.57M |
June 30, 2018 | 16.10M |
March 31, 2018 | 22.59M |
December 31, 2017 | 26.48M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.482M
Minimum
Jun 2023
34.37M
Maximum
Sep 2019
17.62M
Average
16.28M
Median
Total Assets (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 5.357M |
Palatin Technologies Inc | 11.41M |
iBio Inc | 34.02M |
Theriva Biologics Inc | 48.73M |
Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 18.34M |
Shareholders Equity (Quarterly) | -11.80M |